135 related articles for article (PubMed ID: 23454134)
1. DNA delivery via cationic solid lipid nanoparticles (SLNs).
Carrillo C; Sánchez-Hernández N; García-Montoya E; Pérez-Lozano P; Suñé-Negre JM; Ticó JR; Suñé C; Miñarro M
Eur J Pharm Sci; 2013 May; 49(2):157-65. PubMed ID: 23454134
[TBL] [Abstract][Full Text] [Related]
2. A new optimized formulation of cationic solid lipid nanoparticles intended for gene delivery: development, characterization and DNA binding efficiency of TCERG1 expression plasmid.
Fàbregas A; Sánchez-Hernández N; Ticó JR; García-Montoya E; Pérez-Lozano P; Suñé-Negre JM; Hernández-Munain C; Suñé C; Miñarro M
Int J Pharm; 2014 Oct; 473(1-2):270-9. PubMed ID: 24999055
[TBL] [Abstract][Full Text] [Related]
3. Re-dispersible cationic solid lipid nanoparticles (SLNs) freeze-dried without cryoprotectors: characterization and ability to bind the pEGFP-plasmid.
Vighi E; Ruozi B; Montanari M; Battini R; Leo E
Eur J Pharm Biopharm; 2007 Sep; 67(2):320-8. PubMed ID: 17368876
[TBL] [Abstract][Full Text] [Related]
4. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs?
Das S; Ng WK; Tan RB
Eur J Pharm Sci; 2012 Aug; 47(1):139-51. PubMed ID: 22664358
[TBL] [Abstract][Full Text] [Related]
5. Development of solid lipid nanoparticles (SLNs) of lopinavir using hot self nano-emulsification (SNE) technique.
Negi JS; Chattopadhyay P; Sharma AK; Ram V
Eur J Pharm Sci; 2013 Jan; 48(1-2):231-9. PubMed ID: 23153618
[TBL] [Abstract][Full Text] [Related]
6. Solid lipid nanoparticles loaded with insulin by sodium cholate-phosphatidylcholine-based mixed micelles: preparation and characterization.
Liu J; Gong T; Wang C; Zhong Z; Zhang Z
Int J Pharm; 2007 Aug; 340(1-2):153-62. PubMed ID: 17428627
[TBL] [Abstract][Full Text] [Related]
7. Preparation and characterization of Paliperidone loaded solid lipid nanoparticles.
Kumar S; Randhawa JK
Colloids Surf B Biointerfaces; 2013 Feb; 102():562-8. PubMed ID: 23104026
[TBL] [Abstract][Full Text] [Related]
8. Optimization of freeze-drying condition of amikacin solid lipid nanoparticles using D-optimal experimental design.
Varshosaz J; Ghaffari S; Khoshayand MR; Atyabi F; Dehkordi AJ; Kobarfard F
Pharm Dev Technol; 2012; 17(2):187-94. PubMed ID: 21047276
[TBL] [Abstract][Full Text] [Related]
9. Characterization and formulation optimization of solid lipid nanoparticles in vitamin K1 delivery.
Liu CH; Wu CT; Fang JY
Drug Dev Ind Pharm; 2010 Jul; 36(7):751-61. PubMed ID: 20136495
[TBL] [Abstract][Full Text] [Related]
10. Charge-mediated topical delivery of plasmid DNA with cationic lipid nanoparticles to the skin.
Jin SE; Kim CK
Colloids Surf B Biointerfaces; 2014 Apr; 116():582-90. PubMed ID: 24631964
[TBL] [Abstract][Full Text] [Related]
11. Part I: Development and optimization of solid-lipid nanoparticles using Box-Behnken statistical design for ocular delivery of gatifloxacin.
Abul Kalam M; Sultana Y; Ali A; Aqil M; Mishra AK; Aljuffali IA; Alshamsan A
J Biomed Mater Res A; 2013 Jun; 101(6):1813-27. PubMed ID: 23255511
[TBL] [Abstract][Full Text] [Related]
12. Novel cationic solid lipid nanoparticles enhanced p53 gene transfer to lung cancer cells.
Choi SH; Jin SE; Lee MK; Lim SJ; Park JS; Kim BG; Ahn WS; Kim CK
Eur J Pharm Biopharm; 2008 Mar; 68(3):545-54. PubMed ID: 17881199
[TBL] [Abstract][Full Text] [Related]
13. Preparation and characterization of ibuprofen solid lipid nanoparticles with enhanced solubility.
Potta SG; Minemi S; Nukala RK; Peinado C; Lamprou DA; Urquhart A; Douroumis D
J Microencapsul; 2011; 28(1):74-81. PubMed ID: 21171818
[TBL] [Abstract][Full Text] [Related]
14. pDNA condensation capacity and in vitro gene delivery properties of cationic solid lipid nanoparticles.
Vighi E; Ruozi B; Montanari M; Battini R; Leo E
Int J Pharm; 2010 Apr; 389(1-2):254-61. PubMed ID: 20100555
[TBL] [Abstract][Full Text] [Related]
15. Development of solid lipid nanoparticles and nanostructured lipid carriers for improving ocular delivery of acyclovir.
Seyfoddin A; Al-Kassas R
Drug Dev Ind Pharm; 2013 Apr; 39(4):508-19. PubMed ID: 22424312
[TBL] [Abstract][Full Text] [Related]
16. Short- and long-term stability study of lyophilized solid lipid nanoparticles for gene therapy.
del Pozo-Rodríguez A; Solinís MA; Gascón AR; Pedraz JL
Eur J Pharm Biopharm; 2009 Feb; 71(2):181-9. PubMed ID: 18940256
[TBL] [Abstract][Full Text] [Related]
17. Solid lipid nanoparticles coated with cross-linked polymeric double layer for oral delivery of curcumin.
Wang T; Ma X; Lei Y; Luo Y
Colloids Surf B Biointerfaces; 2016 Dec; 148():1-11. PubMed ID: 27588376
[TBL] [Abstract][Full Text] [Related]
18. [PEI-PMMA cationic nanoparticles as carriers for gene transfer].
Feng M; Li P
Yao Xue Xue Bao; 2005 Oct; 40(10):893-7. PubMed ID: 16408804
[TBL] [Abstract][Full Text] [Related]
19. Solid lipid nanoparticles as delivery systems for Gambogenic acid.
Huang X; Chen YJ; Peng DY; Li QL; Wang XS; Wang DL; Chen WD
Colloids Surf B Biointerfaces; 2013 Feb; 102():391-7. PubMed ID: 23010123
[TBL] [Abstract][Full Text] [Related]
20. Formulation design, preparation and physicochemical characterizations of solid lipid nanoparticles containing a hydrophobic drug: effects of process variables.
Das S; Ng WK; Kanaujia P; Kim S; Tan RB
Colloids Surf B Biointerfaces; 2011 Nov; 88(1):483-9. PubMed ID: 21831615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
